Generic placeholder image

Current Drug Abuse Reviews

Editor-in-Chief

ISSN (Print): 1874-4737
ISSN (Online): 1874-4745

Can MDMA Play a Role in the Treatment of Substance Abuse?

Author(s): Lisa Jerome, Shira Schuster and B. Berra Yazar-Klosinski

Volume 6, Issue 1, 2013

Page: [54 - 62] Pages: 9

DOI: 10.2174/18744737112059990005

Price: $65

Abstract

A wider array of treatments are needed for people with substance abuse disorders. Some psychedelic compounds have been assessed as potential substance abuse treatments with promising results. MDMA may also help treat substance abuse based on shared features with psychedelic compounds and recent reports indicating that MDMAassisted psychotherapy can reduce symptoms of PTSD. Narrative reports and data from early investigations found that some people reduced or eliminated their substance use after receiving MDMA, especially in a therapeutic setting. MDMA is a potent monoamine releaser with sympathomimetic effects that may indirectly activate 5-HT2A receptors. It increases interpersonal closeness and prosocial feelings, potentially through oxytocin release. Findings suggest that ecstasy, material represented as containing MDMA, is associated with deleterious long-term effects after heavy lifetime use, including fewer serotonin transporter sites and impaired verbal memory. Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders. However, subjects who received MDMA-assisted psychotherapy in two recent clinical studies were not motivated to seek out ecstasy, and tested negative in random drug tests during follow-up in one study. MDMA could either directly treat neuropharmacological abnormalities associated with addiction, or it could indirectly assist with the therapeutic process or reduce symptoms of comorbid psychiatric conditions, providing a greater opportunity to address problematic substance use. Studies directly testing MDMA-assisted psychotherapy in people with active substance abuse disorder may be warranted.

Keywords: 3, 4-methylenedioxymethamphetamine, entactogen, MDMA, oxytocin, psychedelic, psychotherapy, addiction.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy